Added to YB: 2024-06-13
Pitch date: 2024-06-11
VNDA [bullish]
Vanda Pharmaceuticals Inc.
-27.33%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
Market Cap
$261.8M
Pitch Price
$6.00
Price Target
N/A
Dividend
N/A
Sector
Biotechnology
Category
special_situation
Vanda Pharmaceuticals: 2 Bidders, Entrenched Management, Upcoming Business Catalysts
VNDA: Biopharma w/ commercial & late-stage drugs. $5.40/sh cash after liabilities. Rejected Future Pak's $7.25-$7.75/sh + CVR bid as undervaluing co. Cycle offered $8/sh cash, no CVR. Entrenched mgmt may block sale. Potential higher bids or CEO-led buyout. Small position.
Read full article (4 min)